Clinical Trial Update: A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive Patients

View source ↗

Summary

A completed clinical trial assessed the effects of stopping preventive therapy for Mycobacterium avium complex infection in HIV-positive patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Mycobacterium Avium Complex Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mycobacterium Avium-Intracellulare Infection, HIV Infections | Status: COMPLETED